EP4216910A1 - Skin care formulation - Google Patents
Skin care formulationInfo
- Publication number
- EP4216910A1 EP4216910A1 EP21790025.7A EP21790025A EP4216910A1 EP 4216910 A1 EP4216910 A1 EP 4216910A1 EP 21790025 A EP21790025 A EP 21790025A EP 4216910 A1 EP4216910 A1 EP 4216910A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- group
- oil
- red
- polymer
- skin care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Definitions
- the present invention relates to an oil/polymer blend.
- the present invention relates to a skin care formulation comprising an oil/polymer blend comprising an oil, wherein the oil is selected from the group consisting of silicone fluids, fluids containing 2 to 30 carbon atoms per molecule, and mixtures thereof; a thickening polymer powder, thickening polymer, wherein the thickening polymer is a silylated cellulose polymer, comprising a cellulose polymer functionalized with -SiiR 1 R groups; wherein each R 1 is independently selected from the group consisting of a hydrogen, a Ci-s alkyl group, a Ci-s haloalkyl group, an aryl group, a Ci-s alkylaryl group and a Ci-s haloalkylaryl group; and wherein the cellulose polymer has a weight average molecular weight of 50,000 to 1,500,000 Daltons.
- Konik et al. disclose water proof or water resistant cosmetic compositions which comprise a styrene-ethylene-propylene copolymer in an amount of 5 to 10 %, a combination of a PVP/eicosene copolymer and tricontanyl PVP copolymer in an amount of 0.1 to 50 %, a Cs-9 isoparaffin, a C9-12 aliphatic hydrocarbon, or a combination thereof, in an amount of 50 to 85%.
- the present invention provides an oil/polymer blend comprising: (a) an oil, wherein the oil is selected from the group consisting of silicone fluids, fluids containing 2 to 30 carbon atoms per molecule, and mixtures thereof; and (b) a thickening polymer powder, thickening polymer, wherein the thickening polymer is a silylated cellulose polymer, comprising a cellulose polymer functionalized with -SiiR 1 R groups; wherein each R 1 is independently selected from the group consisting of a hydrogen, a Ci-s alkyl group, a Ci-s haloalkyl group, an aryl group, a Ci-s alkylaryl group and a Ci-s haloalkylaryl group; and wherein the cellulose polymer has a weight average molecular weight of 50,000 to 1,500,000 Daltons.
- the present invention provides an oil/polymer blend comprising: (a) an oil, wherein the oil is a wherein the cosmetically acceptable oil is selected from the group consisting of linear or branched Cs-3o alkanes; Cs-3o alkyl esters; Cs-3o carboxylic acid esters; Cs-3o linear or branched alcohols; silicone fluids; and mixtures thereof; and (b) a thickening polymer powder, thickening polymer, wherein the thickening polymer is a silylated cellulose polymer, comprising a cellulose polymer functionalized with -SiiR 1 fl groups; wherein each R 1 is independently selected from the group consisting of a hydrogen, a Ci-s alkyl group, a Ci-s haloalkyl group, an aryl group, a Ci-s alkylaryl group and a Ci-s haloalkylaryl group; and wherein the cellulose polymer has a weight average molecular weight of
- the present invention provides a skin care formulation, comprising: a cosmetically acceptable carrier; a color ingredient; and an oil/polymer blend, wherein the oil/polymer blend comprises: (a) an oil, wherein the oil is a wherein the cosmetically acceptable oil is selected from the group consisting of linear or branched Cs-3o alkanes; Cs-3o alkyl esters; Cs-3o carboxylic acid esters; Cs-3o linear or branched alcohols; silicone fluids; and mixtures thereof; and (b) a thickening polymer powder, thickening polymer, wherein the thickening polymer is a silylated cellulose polymer, comprising a cellulose polymer functionalized with -Si( R 1 )3 groups; wherein each R 1 is independently selected from the group consisting of a hydrogen, a Ci-s alkyl group, a Ci-8 haloalkyl group, an aryl group, a Ci-8 alkylaryl group and a Ci-8
- the present invention provides a method of enhancing the appearance of skin, comprising: providing a skin care formulation of the present invention, and applying the skin care formulation to skin.
- weight average molecular weight and “M w” are used interchangeably to refer to the weight average molecular weight as measured in a conventional manner with gel permeation chromatography (GPC) and conventional standards, such as polystyrene standards. GPC techniques are discussed in detail in Modem Size Exclusion Liquid Chromatography: Practice of Gel Permeation and Gel Filtration Chromatography, Second Edition, Striegel, et al., John Wiley & Sons, 2009. Weight average molecular weights are reported herein in units of Daltons.
- cosmetically acceptable refers to ingredients typically used in personal care compositions, and is intended to underscore that materials that are toxic when present in the amounts typically found in personal care compositions are not contemplated as part of the present invention.
- an acidic aqueous cleansing formulation refers to visual and tactile sensory properties (e.g., smoothness, tack, lubricity, texture, color, clarity, turbidity, uniformity).
- the oil/polymer blend of the present invention comprises: (a) an oil (preferably, 75 to 99.9 wt% (more preferably, 80 to 99.7 wt%; still more preferably, 85 to 99.6 wt%; most preferably, 90 to 99.5 wt%), based on weight of the oil/polymer blend, of the oil), wherein the oil is selected from the group consisting of silicone fluids, fluids containing 2 to 30 carbon atoms (preferably, 5 to 30 carbon atoms; more preferably 8 to 30 carbon atoms; most preferably, 10 to 25 carbon atoms) per molecule, and mixtures thereof; and (b) a thickening polymer (preferably, 0.1 to 25 wt% (more preferably, 0.3 to 20 wt%; still more preferably, 0.4 to 15 wt%; most preferably, 0.5 to 10 wt%), based on weight of the oil/polymer blend, of the thickening polymer), wherein
- the oil/polymer blend of the present invention comprises 75 to 99.9 wt% (preferably, 80 to 99.7 wt%; more preferably, 85 to 99.6 wt%; most preferably, 90 to 99.5 wt%), based on weight of the oil/polymer blend, of an oil, wherein the oil is selected from the group consisting of silicone fluids, fluids containing 2 to 30 carbon atoms (preferably, 5 to 30 carbon atoms; more preferably 8 to 30 carbon atoms; most preferably, 10 to 25 carbon atoms) per molecule, and mixtures thereof.
- the oil/polymer blend of the present invention comprises 75 to 99.9 wt% (preferably, 80 to 99.7 wt%; more preferably, 85 to 99.6 wt%; most preferably, 90 to 99.5 wt%), based on weight of the oil/polymer blend, of an oil, wherein the oil is selected from the group consisting of silicone fluids, fluids containing 2 to 30 carbon atoms (preferably, 5 to 30 carbon atoms; more preferably 8 to 30 carbon atoms; most preferably, 10 to 25 carbon atoms) per molecule, and mixtures thereof; wherein the oil is a cosmetically acceptable oil.
- the oil/polymer blend of the present invention comprises 75 to 99.9 wt% (preferably, 80 to 99.7 wt%; more preferably, 85 to 99.6 wt%; most preferably, 90 to 99.5 wt%), based on weight of the oil/polymer blend, of an oil, wherein the oil is a cosmetically acceptable oil selected from the group consisting of linear or branched C5-30 alkanes (preferably, C14-22 mineral oil, isododecane, C11/C13 linear alkane blends (e.g., Cetiol Ultimate), hemisqualane; more preferably, isododecane, C11/C13 linear alkane blends (e.g., Cetiol Ultimate), most preferably, isododecane); C5-30 alkyl esters (preferably, 2-methylundecanoate, C12 alkyl benzoate, ethyl decanoate, ethyl dodecanoate
- the oil/polymer blend of the present invention comprises 75 to 99.9 wt% (preferably, 80 to 99.7 wt%; more preferably, 85 to 99.6 wt%; most preferably, 90 to 99.5 wt%), based on weight of the oil/polymer blend, of an oil, wherein the oil is a cosmetically acceptable oil selected from the group consisting of C14-22 mineral oil, isododecane, C11/C13 linear alkane blend, hemisqualane, 2-methylundecanoate, C12 alkyl benzoate, ethyl decanoate, ethyl dodecanoate, pentaerythrityl tetraethylhexanoate, octyldodecyl neopentanoate, tricaprylin, ethylhexyl isononanoate, methylheptyl isostearate, dicaprylyl maleate,
- the oil/polymer blend of the present invention comprises 75 to 99.9 wt% (preferably, 80 to 99.7 wt%; more preferably, 85 to 99.6 wt%; most preferably, 90 to 99.5 wt%), based on weight of the oil/polymer blend, of an oil, wherein the oil is a cosmetically acceptable oil selected from the group consisting of isododecane, caprylyl methicone and mixtures thereof.
- the oil/polymer blend of the present invention comprises 0.1 to 25 wt% (preferably, 1 to 20 wt%; more preferably, 2 to 15 wt%; most preferably, 2.5 to 7.5 wt%), based on weight of the oil/polymer blend, of the thickening polymer; wherein the thickening polymer is a silylated cellulose polymer; wherein the silylated cellulose polymer comprises a cellulose polymer functionalized with -Si(R 1 )3 groups; wherein the cellulose polymer has a weight average molecular weight of 50,000 to 1,500,000 Daltons (preferably, 50,000 to 1,250,000 Daltons; more preferably, 80,000 to 1,150,000 Daltons; most preferably, 100,000 to 1,100,000 Daltons); wherein each R 1 is independently selected from the group consisting of a hydrogen, a Ci-s alkyl group, a Ci-s haloalkyl group, an aryl group, a Ci-s alky
- the oil/polymer blend of the present invention comprises 0.1 to 25 wt% (preferably, 1 to 20 wt%; more preferably, 2 to 15 wt%; most preferably, 2.5 to 7.5 wt%), based on weight of the oil/polymer blend, of a thickening polymer, wherein the thickening polymer is a silylated cellulose polymer; wherein the silylated cellulose polymer comprises a cellulose polymer functionalized with -Si(R 1 )3 groups; wherein the cellulose polymer has a weight average molecular weight of 50,000 to 1,500,000 Daltons (preferably, 50,000 to 1,250,000 Daltons; more preferably, 80,000 to 1,150,000 Daltons; most preferably, 100,000 to 1,100,000 Daltons); wherein each R 1 is independently selected from the group consisting of a hydrogen and a Ci-s alkyl group.
- the oil/polymer blend of the present invention comprises 0.1 to 25 wt% (preferably, 1 to 20 wt%; more preferably, 2 to 15 wt%; most preferably, 2.5 to 7.5 wt%), based on weight of the oil/polymer blend, of a thickening polymer, wherein the thickening polymer is a silylated cellulose polymer; wherein the silylated cellulose polymer comprises a cellulose polymer functionalized with -Si(R 1 )3 groups; wherein the cellulose polymer has a weight average molecular weight of 50,000 to 1,500,000 Daltons (preferably, 50,000 to 1,250,000 Daltons; more preferably, 80,000 to 1,150,000 Daltons; most preferably, 100,000 to 1,100,000 Daltons); wherein each R 1 is independently selected from the group consisting of a Ci-4 alkyl group.
- the oil/polymer blend of the present invention comprises 0.1 to 25 wt% (preferably, 1 to 20 wt%; more preferably, 2 to 15 wt%; most preferably, 2.5 to 7.5 wt%), based on weight of the oil/polymer blend, of a thickening polymer, wherein the thickening polymer is a silylated cellulose polymer; wherein the silylated cellulose polymer comprises a cellulose polymer functionalized with -Si( R 1 )3 groups; wherein the cellulose polymer has a weight average molecular weight of 50,000 to 1,500,000 Daltons (preferably, 50,000 to 1,250,000 Daltons; more preferably, 80,000 to 1,150,000 Daltons; most preferably, 100,000 to 1,100,000 Daltons); wherein each R 1 is independently selected from the group consisting of a C1-2 alkyl group.
- the oil/polymer blend of the present invention comprises 0.1 to 25 wt% (preferably, 1 to 20 wt%; more preferably, 2 to 15 wt%; most preferably, 2.5 to 7.5 wt%), based on weight of the oil/polymer blend, of a thickening polymer, wherein the thickening polymer is a silylated cellulose polymer; wherein the silylated cellulose polymer comprises a cellulose polymer functionalized with -Si(R 1 )3 groups; wherein the cellulose polymer has a weight average molecular weight of 50,000 to 1,500,000 Daltons (preferably, 50,000 to 1,250,000 Daltons; more preferably, 80,000 to 1,150,000 Daltons; most preferably, 100,000 to 1,100,000 Daltons); wherein each R 1 is a methyl group.
- the oil/polymer blend of the present invention comprises 0.1 to 25 wt% (preferably, 1 to 20 wt%; more preferably, 2 to 15 wt%; most preferably, 2.5 to 7.5 wt%), based on weight of the oil/polymer blend, of a thickening polymer, wherein the thickening polymer is a silylated cellulose polymer of formula I wherein n is an average of 308 to 9,252 (preferably, 308 to 6,167; more preferably, 3083 to 4,317); wherein each R 2 is independently selected from the group consisting of a hydrogen, a Ci-8 alkyl group and a -8 i ( R 1 U group (preferably, a hydrogen, a C1-4 alkyl group and a -S i ( R 1 D group; more preferably, a hydrogen, a C1-2 alkyl group and a -Si(R 2 )3 group; most preferably, a hydrogen and a -Si
- the thickening polymer is a silylated cellulose polymer; wherein the silylated cellulose polymer comprises a cellulose polymer functionalized with -Si(R 1 )3 groups having a degree of substitution, DS, of the -Si(R 1 )3 groups of 1.4 to 3.0 (preferably, 1.5 to 3.0; more preferably, 2.0 to 3.0; most preferably, 2.25 to 3.0) determined by Attenuated Total Reflection - Fourier Transform Infrared (ATR-FTIR) Spectroscopy.
- ATR-FTIR Attenuated Total Reflection - Fourier Transform Infrared
- the skin care formulation of the present invention comprises: a cosmetically acceptable carrier (preferably, 30 to 92 wt% (more preferably, 35 to 92 wt%; most preferably, 40 to 80 wt%), based on weight of the skin care formulation, of the cosmetically acceptable carrier); a color ingredient (preferably, 0.01 to 25 wt% (more preferably, 0.1 to 20 wt%; most preferably, 1 to 10 wt%), based on weight of the skin care formulation, of the color ingredient); and an oil/polymer blend (preferably, 5 to 69.9 wt% (more preferably, 7 to 50 wt%; most preferably, 15 to 30 wt%), based on weight of the skin care formulation, of the oil/polymer blend); wherein the oil/polymer blend, comprises: (a) an oil (preferably, 75 to 99.9 wt% (more preferably, 80 to 99.7 wt%; still more preferably, 85 to 99.6 w
- the skin care formulation of the present invention comprises 30 to 92 wt% (preferably, 35 to 92 wt%; more preferably, 40 to 80 wt%), based on weight of the skin care formulation, of a cosmetically acceptable carrier. More preferably, the skin care formulation of the present invention, comprises 30 to 92 wt% (preferably, 35 to 92 wt%; more preferably, 40 to 80 wt%), based on weight of the skin care formulation, of a cosmetically acceptable carrier; wherein the color ingredient and the oil/polymer blend are dispersed in the cosmetically acceptable carrier.
- the skin care formulation of the present invention comprises 30 to 92 wt% (preferably, 35 to 92 wt%; more preferably, 40 to 80 wt%), based on weight of the skin care formulation, of a cosmetically acceptable carrier; wherein the color ingredient and the oil/polymer blend are dispersed in the cosmetically acceptable carrier.
- the skin care formulation of the present invention comprises 30 to 92 wt% (preferably, 35 to 92 wt%; more preferably, 40 to 80 wt%), based on weight of the skin care formulation, of a cosmetically acceptable carrier; wherein the color ingredient and the oil/polymer blend are dispersed in the cosmetically acceptable carrier.
- the skin care formulation of the present invention comprises 30 to 92 wt% (preferably, 35 to 92 wt%; more preferably, 40 to 80 wt%), based on weight of the skin care formulation, of a cosmetically acceptable carrier; wherein the cosmetically acceptable carrier is selected to be capable of evaporating upon application of the skin care formulation to mammalian skin (preferably, human skin).
- the skin care formulation of the present invention comprises 30 to 92 wt% (preferably, 35 to 92 wt%; more preferably, 40 to 80 wt%), based on weight of the skin care formulation, of a cosmetically acceptable carrier; wherein the cosmetically acceptable is selected from the group consisting of water (e.g., deionized, distilled water); short chain alcohols (e.g., C1-4 straight or branched chain alcohols such as methyl alcohol, ethyl alcohol, propyl alcohol, isopropyl alcohol, butyl alcohol); glycols (e.g., ethylene glycol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol, ethoxy diglycol); cyclosiloxanes (e.g., cyclopentasiloxane, cyclohexasiloxane); glycerin; isododecane;
- a cosmetically acceptable carrier
- the skin care formulation of the present invention comprises 30 to 92 wt% (preferably, 35 to 92 wt%; more preferably, 40 to 80 wt%), based on weight of the skin care formulation, of a cosmetically acceptable carrier; wherein the cosmetically acceptable carrier includes at least one of water and isododecane (preferably, at least one of deionized water, distilled water and isododecane; more preferably, at lease one of deionized water and isododecane).
- the cosmetically acceptable carrier includes at least one of water and isododecane (preferably, at least one of deionized water, distilled water and isododecane; more preferably, at lease one of deionized water and isododecane).
- the skin care formulation of the present invention comprises a color ingredient. More preferably, the skin care formulation of the present invention comprises a color ingredient; wherein the color ingredient is selected from the group consisting of inorganic pigments, organic pigments, dyes, aqueous pigment dispersions and mixtures thereof. Still more preferably, the skin care formulation of the present invention comprises a color ingredient; wherein the color ingredient is selected from the group consisting of Ext. D&C Yellow No. 2, Ext. D & C Violet No. 2, FD&C Red No. 4, FD&C Red No. 40, FD&C Yellow No. 5, FD&C Yellow No. 6, FD&C Green No. 3, FD&C Blue No. 1, D&C Yellow No.
- D&C Yellow No. 8 D&C Yellow No. 10, D&C Yellow No. 11, D&C Violet No. 2, D&C Red No. 6, D&C Red No. 7, D&C Red No. 17, D&C Red No. 21, D&C Red No. 22, D&C Red No. 27, D&C Red No. 28, D&C Red No. 30, D&C Red No. 31, D&C Red No. 34, D&C Red No. 33, D&C Red No. 36, D&C Green No. 5, D&C Green No. 6, D&C Green No. 8, D&C Blue No. 4, D&C Orange No. 4, D&C Orange No. 5, D&C Orange No. 10, D&C Orange No. 11, D&C Brown No.
- the skin care formulation of the present invention comprises a color ingredient; wherein the color ingredient includes at least one iron oxide and titanium dioxide. Most preferably, preferably, the skin care formulation of the present invention comprises a color ingredient; wherein the color ingredient includes a mixture of iron oxides and titanium dioxide.
- the skin care formulation of the present invention optionally, further comprises an optional additive. More preferably, the skin care formulation of the present invention, further comprises an optional additive, wherein the optional additive is selected from the group consisting of suncare actives, film formers, emollients, preservatives, antioxidants, fragrances, humectants, rheology modifiers, aesthetic modifiers, vitamins, skin protectants, oils, emulsifiers, surfactants, pearlizers, consistency factors, thickeners, super fatting agents, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, fillers, light management powders and particles, and mixtures thereof.
- the optional additive is selected from the group consisting of suncare actives, film formers, emollients, preservatives, antioxidants, fragrances, humectants, rheology modifiers, aesthetic modifiers, vitamins, skin protectants, oils, emulsifiers, surfactants, pearlizers, consistency
- the skin care formulation of the present invention further comprises a suncare active. More preferably, the skin care formulation of the present invention further comprises a suncare active; wherein the suncare active is a UV radiation absorbing agent. Still more preferably, the skin care formulation of the present invention, further comprises a suncare active, wherein the suncare active is a UV radiation absorbing agent selected from the group consisting of physical blockers (e.g., red petrolatum, titanium dioxide, zinc oxide) and chemical absorbers (e.g., l-(4-methoxyphenol)-3-(4-tert-butylphenyl)propane-l, 3-dione (INCI: Butyl Methoxy dibenzoylmethane); 2-hydroxy-4-methoxybenzophenone (INCI: Benzophenone-3); dioxybenzone; sulisobenzone; menthyl anthranilate; para-aminobenzoic acid; amyl paradimethylaminobenzoic
- 2-ethylhexyl-2-hydroxybenzoate (INCI: Ethylhexyl Salicylate); homomenthyl salicylate; glyceryl aminobenzoate; triethanolamine salicylate; digalloyl trioleate; lawsone with dihydroxyacetone; 2-phenylbenzimidazole-5-sulfonic acid; 4-methylbenzylidine camphor; avobenzone; triazines; benzotriazoles; vinyl group-containing amides; cinnamic acid amides; sulfonated benzimidazoles); 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate (INCI: Homosalate).
- the skin care formulation of the present invention further comprises of a suncare active, wherein the suncare active is a UV radiation absorbing agent comprises a mixture of UV radiation absorbing agents.
- the skin care formulation of the present invention comprises a suncare active, wherein the suncare active is a UV radiation absorbing agent is a mixture of UV absorbing agents including at least one of titanium dioxide; l-(4-methoxyphenol)-3-(4-tert-butylphenyl)propane-l, 3-dione; 2-ethylhexyl-2-hydroxybenzoate; 2-ethyhexyl-2-cyano-3,3-diphenyl-2-propenoate; 2-hydroxy-4-methoxybenzophenone and 3, 3, 5 -trimethylcyclohexyl 2-hydroxybenzoate.
- the skin care formulation of the present invention has a pH of 4 to 9. More preferably, the skin care formulation of the present invention has a pH of 4.5 to 8.5. Still more preferably, the skin care formulation of the present invention has a pH of 5.0 to 8.0. Most preferably, the skin care formulation of the present invention has a pH of 5.5 to 7.5.
- the skin care formulation of the present invention is provided a product form selected from the group consisting of a cream, an aqueous solution, an emulsion (e.g., water-in-oil emulsion, oil-in-water emulsion), an oil, an ointment, a paste, a gel, a lotion, a milk, a foam, a stick and a suspension.
- an emulsion e.g., water-in-oil emulsion, oil-in-water emulsion
- an oil e.g., water-in-oil emulsion, oil-in-water emulsion
- an oil e.g., an ointment
- a paste e.g., a gel, a lotion, a milk, a foam, a stick and a suspension.
- the skin care formulation of the present invention are useful for enhancing the appearance of skin through application to the skin.
- the skin care formulation of the present invention applies easily to the skin, leaving a clear vivid color that remains in place at least through the work day and preferably thereafter.
- xylene (Xyl) was added to the flask contents in the amount noted in TABLE 1 and the flask contents were then heated to set temperature, T2, noted in TABLE 1 and stirred for time, t 2 , in hours noted in TABLE 1.
- the product solution was then transferred to a separatory funnel and subjected to non-solvent precipitation by dropwise addition into two liters of vigorously stirring methanol.
- the product was precipitated in the form of a thread or flakes.
- the product was isolated by filtration, and the product was dried in a vacuum oven at 50 °C overnight.
- the product was then suspended in 500 mL of methanol and left overnight, then refiltered and dried in vacuum oven at 50 °C overnight.
- the degree of substitution, DS, of -Si(CH3)3 in the thickening polymers prepared according to Examples S1-S25 was determined using well known techniques based on Attenuated Total Reflection - Fourier Transform Infrared Spectroscopy analyzing spectra peak areas calculated with MATLAB using the spectral parameters provided in TABLE 2 with the DS values determined as reported in TABLE 3.
- the skin care formulations of Comparative Example Cl and Examples 1-4 were prepared having the formulation noted in TABLE 4.
- the Phase B ingredients were mixed in a separate container.
- the Phase C ingredients were combined in a separate container with mixing until uniform.
- the Phase A and D ingredients were combined in a separate beaker and mixed until uniform.
- the mixed Phase C ingredients were then added to the combined Phase A and D ingredients with shear at 450 rpm until homogeneous.
- the mixed Phase B ingredients were then slowly added to the combined Phase A, C and D ingredients with shear at 700 rpm.
- the combined formulation was then mixed for an additional 5 minutes with shear at 2,000 rpm to provide the product skin care formulation.
- Examples 1-4 was determined using a TA Instruments DHR-3 rheometer at 25 °C, equipped with a stainless steel 60 mm, 0.5° cone and plate sensor, a gap set at 17 microns and a shear rate of 6.31 s’ 1 . Shear sweep method was used with shear rate ranges from 0.01 s’ 1 to 100 s’ 1 . Viscosities measured at low shear (0.1 s’ 1 ) and high shear (100 s’ 1 ) are reported in TABLE 5.
- the skin care formulations prepared according to Comparative Examples C2-C3 and Examples 5-9 were each coated on a white vinyl chart (available from Leneta) using a doctor blade film applicator with the gap set at 6 mils (0.1524 mm) and allowed to dry at 22 °C for at least 48 hours. The color reading of each sample was then measured by colorimeter (Ocean Optics).
- the wear resistance of the deposited film of skin care formulations was characterized by the change (AE) before and after abrasion with a pre-cut bath towel (55 mm x 45 mm). The bath towel was fixed to a moving robotic part that moves back and forth periodically at a constant speed.
- the film was abraded by the bath towel by 3 and 6 wear cycles under a pressure of approximately 600 Pa, each wear cycle lasts 6 seconds. Readings were taken from ten point on each deposited film. The average of the readings from each sample is provided in TABLE 7. Lower AE indicates less color change after rub-off and higher wear resistance. The AE of the inventive polymers were lower than the commercial material, which is highly favorable for skin care formulations to enable long lasting performance.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063082768P | 2020-09-24 | 2020-09-24 | |
| PCT/US2021/051168 WO2022066592A1 (en) | 2020-09-24 | 2021-09-21 | Skin care formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4216910A1 true EP4216910A1 (en) | 2023-08-02 |
| EP4216910B1 EP4216910B1 (en) | 2025-09-17 |
Family
ID=78086160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP21790025.7A Active EP4216910B1 (en) | 2020-09-24 | 2021-09-21 | Skin care formulation |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230310298A1 (en) |
| EP (1) | EP4216910B1 (en) |
| JP (1) | JP2023544098A (en) |
| KR (1) | KR20230070477A (en) |
| CN (1) | CN116322627A (en) |
| WO (1) | WO2022066592A1 (en) |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2953601B2 (en) * | 1992-11-12 | 1999-09-27 | 信越化学工業株式会社 | Nail polish |
| US5959009A (en) | 1997-10-31 | 1999-09-28 | E-L Management Corp | Mascara waterproofing composition |
| FR2784107B1 (en) * | 1998-09-15 | 2005-12-09 | Rhodia Chimie Sa | SURFACE MODIFIED CELLULOSE MICROFIBRILLES, THEIR PREPARATION PROCESS, AND THEIR USE |
| JP2000273780A (en) * | 1999-03-24 | 2000-10-03 | Japan Science & Technology Corp | Low molecular weight cellulose extracted from cocodomo and its preparation method |
| DE10006603A1 (en) * | 2000-02-15 | 2001-08-16 | Clariant Gmbh | Hydrophobically modified cellulose ethers, processes for their preparation and their use |
| JP3775486B2 (en) * | 2001-07-18 | 2006-05-17 | 信越化学工業株式会社 | Coating composition for urine-treated granules for domestic animals and urine-treated granules |
| GB0818419D0 (en) * | 2008-10-08 | 2008-11-12 | Imp Innovations Ltd | Nanocomposites |
| US8524887B2 (en) * | 2009-04-15 | 2013-09-03 | Eastman Chemical Company | Regioselectively substituted cellulose esters produced in a tetraalkylammonium alkylphosphate ionic liquid process and products produced therefrom |
| CN104010695B (en) * | 2011-09-29 | 2017-09-15 | 罗门哈斯公司 | Personal care composition and method containing hydrophobically modified hydroxyethyl cellulose |
| JP6058904B2 (en) * | 2012-03-26 | 2017-01-11 | 株式会社 資生堂 | Oil-in-water emulsified cosmetic |
| KR102138546B1 (en) * | 2012-08-24 | 2020-07-28 | 다우 글로벌 테크놀로지스 엘엘씨 | Partially cross-linked esterified cellulose ethers |
| US9187865B2 (en) * | 2012-11-30 | 2015-11-17 | Api Intellectual Property Holdings, Llc | Processes and apparatus for producing nanocellulose, and compositions and products produced therefrom |
| SG11201602439RA (en) * | 2013-11-01 | 2016-04-28 | Gillette Co | Shave care composition for a liquid dispensing razor |
| JP6279457B2 (en) * | 2013-11-19 | 2018-02-14 | 株式会社 資生堂 | Oil-in-water emulsified cosmetic |
| CN106572958B (en) * | 2014-11-28 | 2020-11-06 | 株式会社资生堂 | Oil-in-water type emulsion cosmetic |
| EP3081209A1 (en) * | 2015-04-13 | 2016-10-19 | Borregaard AS | Skin care compositions comprising microfibrillated cellulose |
| JP6828040B2 (en) * | 2015-12-21 | 2021-02-10 | ロレアル | Compositions containing alkyl cellulose and incompatible hydrocarbons and silicone oils and methods using them |
| CN107236352B (en) * | 2017-07-24 | 2020-12-08 | 上海融澈水性材料有限公司 | Aqueous coating film-forming additive composition and preparation method thereof |
| TW202023523A (en) * | 2018-10-11 | 2020-07-01 | 美商陶氏全球科技責任有限公司 | Color cosmetic formulation |
-
2021
- 2021-09-21 CN CN202180069332.3A patent/CN116322627A/en active Pending
- 2021-09-21 US US18/023,155 patent/US20230310298A1/en active Pending
- 2021-09-21 JP JP2023517744A patent/JP2023544098A/en active Pending
- 2021-09-21 WO PCT/US2021/051168 patent/WO2022066592A1/en not_active Ceased
- 2021-09-21 EP EP21790025.7A patent/EP4216910B1/en active Active
- 2021-09-21 KR KR1020237013129A patent/KR20230070477A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230070477A (en) | 2023-05-23 |
| CN116322627A (en) | 2023-06-23 |
| JP2023544098A (en) | 2023-10-20 |
| US20230310298A1 (en) | 2023-10-05 |
| EP4216910B1 (en) | 2025-09-17 |
| WO2022066592A1 (en) | 2022-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5931832B2 (en) | Aqueous dispersion of silicone rubber particles, silicone rubber particles, and cosmetics | |
| JP5770094B2 (en) | New organopolysiloxane copolymer | |
| CN112386504B (en) | Dispersible powders and cosmetics | |
| US11033481B2 (en) | Silicone resin, making method, and cosmetics | |
| CN111225920B (en) | Urea group-containing organopolysiloxane, method for preparing urea group-containing organopolysiloxane, and cosmetics | |
| JP7240345B2 (en) | cosmetics | |
| JP2009132638A (en) | Cosmetic | |
| US12514802B2 (en) | Polymer/hydrophobic ester oil blend | |
| WO2023223800A1 (en) | Organopolysiloxane, powder treatment agent, and treated powder and cosmetic treated with powder treatment agent | |
| JP5345309B2 (en) | Cosmetics | |
| JP6875256B2 (en) | How to make cosmetics | |
| EP4216910B1 (en) | Skin care formulation | |
| CN120418327A (en) | Organopolysiloxane and cosmetic containing the same | |
| WO2024058043A1 (en) | Water-in-oil cosmetic composition | |
| JP6858510B2 (en) | Water-in-oil emulsified cosmetic | |
| JP7787768B2 (en) | Surfactants and cosmetics | |
| JP2009084188A (en) | Cosmetics | |
| WO2023106180A1 (en) | Oil-gelling agent and cosmetic | |
| KR20250119562A (en) | Personal care composition comprising a volatile alkane mixture and a nonvolatile oil | |
| CN121219345A (en) | Organopolysiloxanes and cosmetics containing organopolysiloxanes | |
| WO2024171990A1 (en) | Carboxy group-modified organopolysiloxane having (poly)glycerol group or polyoxyalkylene group, and cosmetic preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20230414 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20231109 |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20240205 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20250516 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602021038834 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20250925 Year of fee payment: 5 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20251020 Year of fee payment: 5 Ref country code: FR Payment date: 20250930 Year of fee payment: 5 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20250930 Year of fee payment: 5 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20251217 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20251218 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20251217 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1837691 Country of ref document: AT Kind code of ref document: T Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20260117 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20260119 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250917 |